Source: Novartis’ Cosentyx and Celgene’s Otezla aren’t just battling it out in the psoriasis arena. As of early this year, they’re competing in psoriatic arthritis, too—and each drugmaker made its case this week with new data in that disease. Cosentyx can steadily improve the signs and symptoms of psoriatic arthritis—including…...